Study uncovers how beta blockers could halt the progression of triple negative breast cancer

Monash University researchers have identified a molecular biomarker in triple negative breast cancer (TNBC) tumors which could inform when beta blockers can play a role in “switching off” tumor progression.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup